Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...

Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...

About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...

Patients who have a cancer diagnosis and also struggle to find the financial means to pay for needed oncology services tend to have worse outcomes, according to the Association of Community Cancer ...

Global research study investigates patient and caregiver awareness of and enrollment in rare disease support programs, services and organizations Rare diseases require ongoing support. Our new global ...

About 1 in 10 prescription drugs - mainly brand-name and expensive drugs and those for rare diseases - has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or ...

Researchers sought to determine the effectiveness of patient navigation for younger breast cancer patients, and their attendance to referrals.

Alyson B. Moadel-Robblee, of Montefiore Einstein Comprehensive Cancer Center discusses the BOLD Program, offering support and wellness resources. In an interview with CURE, Alyson B. Moadel-Robblee, ...